Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

REL proto-oncogene (c-Rel) Peptide

Rockland 100-4166p c-Rel Host: Synthetic Sodium azide
Rockland
Catalog No. ABIN964100
Supplier Product No.: 100-4166p
  • Target See all c-Rel products
    c-Rel (REL proto-oncogene (c-Rel))
    Peptide Type
    Synthetic
    Source
    • 7
    Synthetic
    Supplier Product No.
    100-4166p
    Supplier
    Rockland
    Purpose
    NFkB cRel Peptide
    Characteristics
    NFKB peptide, cRel peptide, Nuclear factor NF-kappa-B p105 subunit, DNA-binding factor KBF1, EBP-1 antibody, control peptide, blocking peptide
    Purity
    Greater than 95% specific peptide
    Sterility
    Sterile filtered
  • Application Notes

    Application Note: Control peptide should be used at 1.0 μg per 1.0 μL of antiserum in per assay.

    Other: Control peptide should be used at 1.0 μg per 1.0 μL of antiserum per assay. 

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1.0 mg/mL
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
    Expiry Date
    6 months
  • Target
    c-Rel (REL proto-oncogene (c-Rel))
    Background
    Background: Intended for use as a control peptide when used with anti-NFB cRel to block specific interaction of anti-NFB cRel (p/n 100-4166) with the NFB cRel subunit. NFkB was originally identified as a factor that binds to the immunoglobulin kappa light chain enhancer in B cells. It was subsequently found in non-B cells in an inactive cytoplasmic form consisting of NFkB bound to IkB. NFkB was originally identified as a heterodimeric DNA binding protein complex consisting of p65 (RelA) and p50 (NFKB1) subunits. Other identified subunits include p52 (NFKB2), c-Rel, and RelB. The p65, cRel, and RelB subunits are responsible for transactivation. The p50 and p52 subunits possess DNA binding activity but limited ability to transactivate. p52 has been reported to form transcriptionally active heterodimers with the NFkB subunit p65, similar to p50/p65 heterodimers. The heterodimers of p52/p65 and p50/p65 are regulated by physical inactivation in the cytoplasm by IkB-a. IkB-a binds to the p65 subunit, preventing nuclear localization and DNA binding. Low levels of p52 and p50 homodimers can also exist in cells.
You are here:
Support